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Abstract
Plasmodium falciparum malaria remains one of the world’s foremost health problems, primarily in highly endemic regions
such as Sub-Saharan Africa, where it is responsible for substantial morbidity, mortality and economic losses. Malaria is a
significant cause of severe disease and death in pregnant women and newborns, with pathogenesis being associated with
expression of a unique variant of the multidomain Plasmodium falciparum Erythrocyte Membrane Protein 1 (PfEMP1) called
VAR2CSA. Here, we characterize the polymorphism of the DBL3X domain of VAR2CSA and identify regions under selective
pressure among placental parasites from women living in endemic western Kenya. In addition to significant levels of
polymorphism, our analysis reveals evidence for diversification through intra-segmental recombination and novel mutations
that likely contributed to the high number of unique VAR2CSA sequence types identified in this study. Interestingly, we also
identified a number of critical residues that may be implicated in immune evasion through switching (or toggling) to
alternative amino acids, including an arginine residue within the predicted binding pocket in subdomain III, which was
previously implicated in binding to placental CSA. Overall, these findings are important for understanding parasite diversity
in pregnant women and will be useful for identifying epitopes and variants of DBL3X to be included in a vaccine against
placental malaria.
Citation: Talundzic E, Shah S, Fawole O, Owino S, Moore JM, et al. (2012) Sequence Polymorphism, Segmental Recombination and Toggling Amino Acid Residues
within the DBL3X Domain of the VAR2CSA Placental Malaria Antigen. PLoS ONE 7(2): e31565. doi:10.1371/journal.pone.0031565
Editor: Georges Snounou, Universite ´ Pierre et Marie Curie, France
Received October 13, 2011; Accepted January 13, 2012; Published February 9, 2012
Copyright:  2012 Talundzic et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the National Institutes of Health grant R01 AI050240 to JMM, and University of Georgia Department of Infectious Diseases
research funds to DSP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: dspete@uga.edu
Introduction
Malaria in pregnancy is a disease syndrome with devastating
social and medical complications requiring multidimensional
solutions. Despite intensified international efforts to reduce the
malaria burden in the developing world, it is estimated that more
than 54 million cases of malaria occur every year in reproductive
age women [1]. Placental malaria (PM) results from massive
sequestration of Plasmodium falciparum infected erythrocytes in the
intervillous space of the placenta, causing severe clinical symptoms
that result in maternal morbidity, low birth weight and/or
neonatal death [2].
Malaria-induced morbidity and mortality is largely attributable
to the cytoadherent nature of Plasmodium falciparum infected
erythrocytes. This cytoadherence is mediated by P. falciparum
erythrocyte membrane protein 1 (PfEMP1), a parasite protein
encoded by the highly polymorphic var gene family and expressed
at the surface of the infected erythrocytes. During pregnancy,
expression of a single member of the var gene family, var2csa,
mediates binding to a form of chondroitin sulfate A (CSA) unique
to the placenta [3,4,5,6,7]. Several studies have shown that, after
multiple pregnancies, women in malaria endemic regions develop
antibodies that inhibit infected erythrocyte binding to CSA
[8,9,10], supporting the notion that a vaccine based on placenta-
sequestering parasites could provide protection against PM.
Furthermore, evidence for the presence of a conserved antigen
or shared epitopes in CSA-adherent parasites has been demon-
strated by the fact that plasma and parasites from pregnant women
from different malaria endemic regions show cross-reactivity [11].
This implies that antibody recognition is not dependent on
geographical origin of the parasites and that a vaccine to protect
against PM is feasible.
Interestingly, while highly polymorphic compared to most
malarial antigens, var2csa is the most conserved PfEMP1 identified
to date [3,12], making it an attractive candidate for vaccine
development. It is well-known that VAR2CSA is specifically up-
regulated during PM or when selected in vitro for CSA binding
[13], and disruption of the var2csa gene leads to loss or significant
reduction of infected erythrocyte adhesion to CSA [14].
VAR2CSA consists of six Duffy-binding-like (DBL) domains, a
large interdomain region (ID2) and a C-terminal region predicted
to be cytoplasmic [15]. As reported previously, four of the six DBL
domains (DBL2x, DBL3x, DBL5e, and DBL6e) have been shown
to bind CSA [16,17], although this is controversial [18,19,20]. In
order to design molecular interventions against PM, it is important
to determine the minimal CSA binding regions and understand
how variability is distributed in the individual domains of
VAR2CSA.
The DBL3X and DBL4 e domains have been shown to be
most conserved of the six DBL domains of VAR2CSA [21].
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the DBL3X domain show the most cross-reactivity with
heterologous parasites compared to the other binding domains
[22]. Furthermore, as suggested by Barfod et al. [23], antibody-
mediated immunity is predominantly acquired by malaria-
exposed women to DBL3X and DBL5. Srivastava et al. [19]
demonstrated recently that a recombinant protein containing
DBL1X, DBL2x and DBL3X are required to achieve similar
CSA binding characteristics as the full-length VAR2CSA, and
inhibitory antibodies raised against full-length VAR2CSA target
principally the DBL3X domain. Lastly, Dahlback et al. [20]
recently showed that expression constructs with the highest
affinity binding similar to that of full-length VAR2CSA included
the DBL3X domain. Collectively, these studies provide good
evidence that the DBL3X domain can induce strong protective
immunity, plays an important role in conferring higher binding
specificity in the presence of the N-terminal domains, and owing
to its sequence conservation, make it an excellent target for
vaccine development.
The focus of this study was to characterize the complexity of
var2csa genotypes within naturally infected placentae and investi-
gate patterns of sequence polymorphism within the DBL3X
domain. Here we determined the sequence of var2csa DBL3X
amplified from Kenyan placental parasites and applied computa-
tional and molecular modeling methods to investigate polymor-
phism, recombination and selection within this domain.
Results and Discussion
Var2csa DBL3X domain shows a high degree of
complexity within individuals
To enable complete characterization of var2csa polymorphism
in placental parasite populations, the DBL3X region from 12
maternal placental blood samples was amplified. Five samples
were from primigravid, two from secundigravid, and five from
multigravid women. Complete sequences from an average of
nine clones per sample were obtained. As a control, three
independent plasmids containing the FCR3 DBL3X domain
were also sequenced. These yielded identical sequences, with
100% sequence identity with the FCR3 var2csa DBL3X
sequence in GenBank (GenBank accession number
AY372123). Overall, 108 sequences were obtained, of which
79 were unique at the nucleotide level when compared to these
samples and existing DBL3X sequences in GenBank (Table 1).
Seventy-six of these 79 sequences were also unique at the amino
acid level, demonstrating a very high ratio of nonsynonymous to
synonymous mutations. In total there were 107 novel mutations
a tt h en u c l e o t i d el e v e l .M o s to ft he sequences obtained differed
by 5 or more nucleotides in pairwise comparisons, indicating
true unique sequences. Indeed of the 3081 possible pairwise
comparisons between these sequences, only 73 demonstrated 4
or fewer nucleotide differences. The most interesting finding
obtained from these data is the surprising degree of complexity
observed within individual patient samples. Among the 12
placental samples, half showed nine or more unique var2csa
DBL3X sequence types. It is clear from this work that the
majority of the placental infections are highly complex with
regard to var2csa sequence types, arguably the most relevant
measure of parasite diversity for PM studies. It is possible that
the high number of var2csa sequence types reported here is due
in part to parasites having multiple var2csa genes. While haploid
in the human host, recent work has demonstrated that some
isolates of P.falciparum contain more than one copy of var2csa
[24], which may provide a selective advantage during the course
of infection in pregnant women [25]. Furthermore, Brolin et.al.
[26] has provided compelling evidence that both var2csa genes
are transcribed simultaneously, suggesting var2csa expression in
not a mutually exclusive process. To assess the number of
unique genotypes within the Kenyan samples with a more
conventional technique, we utilized a microsatellite analysis
using seven markers (TA1, poly a, PfPK2, TA109, C2M34,
C3M69). Our results indicate that the multiplicity of infection
(MOI) ranged between 1–4 unique genotypes (Table 2).
Whether due to greater polymorphism in var2csa than in the
microsatellite markers, or to the potential for more than one
copy of the gene to be present in a single genome, our results
show 2–4 times more genetic complexity at the var2csa locus
relative to loci tested in the microsatellite analysis. It is
interesting to compare these findings with other studies
conducted to assess MOI during pregnancy in Africa. Some of
these studies used gel based PCR-RFLP analysis methods, and
reported MOIs ranging from 1.5 to 4 [27,28]. Another study
used a quantitative Gene scan me t h o da n df o u n daM O Io f5 . 6 ,
suggesting that more sensitive methods are likely to detect
higher MOIs [29]. The studies conflicted on the relationship
between gravidity and MOI, with one study finding a negative
correlation [29], and another finding no association [27]. Three
other studies, two in Gabon [30,31] and one in Ghana [32], also
reported relatively low MOI (range of mean MOI 1.5–3). Again
there was disagreement as to a correlation between gravidity
and MOI as one study found decreased MOI with increasing
gravidity [32] while the other found no correlation between
MOI and age (an approximation for gravidity) [30]. Taken
together, these studies found a variable MOI for placental
parasite populations, but arrived at this conclusion via different
techniques. While no correlation between genetic complexity
within var2csa and gravidity was observed in the samples tested
here, such an association, whether due to a higher multiplicity of
infection or the multicopy nature of the var2csa gene in some
isolates, likely needs to be tested by deeper analysis of the degree
of complexity of placental infections.
Using these data, the 79 unique DBL3x sequences were further
characterized by constructing a maximum likelihood tree
(Figure 1). One interesting feature of the tree is that sequences
from the same patient sample tend to group together in one to
three clades. With the exception of one sequence, 0786-A09
(denoted with an asterisk), no sequences from one patient grouped
in a clade with those of another patient. This result is in conflict
with a similar analysis of 43 DBL3x sequences from 24 Senegalese
placental samples by Dahlback et al. [33], who reported that
sequences from different patient samples cluster together in
distinct clades. Although it is difficult to know the precise reason
for this discrepancy, the observed differences are likely due to the
differences in study sample populations, transmission rates and the
time span over which the samples were collected. In particular,
one potential interpretation of this sequence grouping by patient
among Kenyan samples is that the women came from different
villages separated enough geographically to have distinct parasite
populations, although no data were available to directly address
this possibility.
Diversification within the var gene family has been associated
with segmental gene recombination and gene conversion events
[34,35]. It has been recently demonstrated that P. falciparum has a
relatively high recombination rate (RR) [36], including evidence of
segmental gene recombination within var2csa alleles [37]. To
identify whether the Kenyan samples diversified by novel amino
acid mutations and/or segmental recombination, we analyzed the
var2csa sequences using the Recombination Detection Program 4
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S1). The method and guidelines used in RDP4 for identifying
recombination events at the global level (all sequences) and within
the individual samples (same patient clusters) is shown in Figure 2.
The data herein (Figure 2) represent analysis of recombination
breakpoints related to the sequence of the transferred fragment
(major parent sequence) and sequence closely related to the
transferred fragment (minor parent) including the resulting
recombinant, shown in Table S2. Considering all samples, the
results of the RDP4 analysis revealed 14 unique recombination
events, including evidence of recombination between sequences
from different patients. Interestingly, analysis of sequences from
individual patients suggests that more recombination is found at
this level. As mentioned above, this could be due to geographic
separation of patients, with each patient sample set reflecting
recombination and diversification events occurring in an isolated
locale. Although patient data collection did not include location of
residence, it would be very interesting to assess this in future
studies.
Selective pressure in the DBL3X domain shows high
sequence diversity and positive selection
Analysis of sequence polymorphism at the population level is an
effective tool for detecting influence of continuing selection. Sites
experiencing selection show either a decrease or increase in the
density of polymorphism. To further investigate DBL3X poly-
Table 1. Summary of patient gravidity, total number of DBL3X sequences obtained, the number of clones sequenced and among
these the number that were unique, and the nucleotide diversity.
Sample Gravidity Parasitemia Per 300 WBCs Clones Unique (nt/aa) p
Pairwise Identity
(%)
Peripheral Placental
0593 P 24 3942 9 9/8 0.0047 99.5
0626 P 5 251 7 6/5 0.0401 94.4
0659 P 871 1745 8 7/6 0.0342 96.3
0696 P 798 1353 13 11/11 0.0447 93.1
0895 P 200 2534 11 2/2 - 99.9
0661 S 147 5429 10 9/9 0.0419 93.0
0786 S 563 4097 12 5/5 0.0366 95.8
0551 M 18 4 8 2/2 - 99.0
0608 M 650 929 9 9/9 0.0346 95.1
0694 M 242 325 11 9/9 0.0199 95.3
0833 M 3 15 9 9/9 0.0539 94.1
0855 M 3 72 1 1/1 - -
Totals: 108 79/76
The value of p denotes the observed average pairwise nucleotide diversity.
doi:10.1371/journal.pone.0031565.t001
Table 2. Summary of multi-locus genotyping using seven different markers (TA1, poly a, PfPK2, TA109, 2490, C2M34, and C3M69).
DNW denotes loci for which there was no amplification after two attempts.
Chromosome 6 4 12 6 10 2 3
Locus TA1 Polya PfPK2 TA109 2490 C2M34 C3M69
Sample ID Genotypes 1 3 7 9 12 313 383
M0551 2 181 DNW DNW 148 & 160 80 DNW DNW
P0593 2 74 & 199 154 160 164 & 175 83 223 DNW
M0608 4 169 & 180 141, 144 & 151 162, 165, 169 & 184 140, 150 & 164 80 & 83 230 123
P0626 2 181 151 & 173 169 & 172 149 & 160 83 223 & 234 143 & 153
P0659 3 166 151 & 170 DNW 164, 167 & 175 83 DNW DNW
S0661 4 159 137 & 170 163, 166, 169 & 184 146, 157, 163 & 176 80 & 83 DNW 123
P0696 1 DNW 170 163 200 80 255 135
S0786 4 175 147, 176 & 179 172 & 175 160, 163, 172 & 175 80 & 83 221, 230 & 234 149
M0833 3 74, 165 & 171 164 160 & 162 160, 163 & 175 83 223 & 232 118
P0895 2 166 167 165 167 & 178 86 243 140
doi:10.1371/journal.pone.0031565.t002
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diversity across the sequences was calculated, and Tajima’s
Neutrality Test was applied to reveal selection hotspots (see
Materials and Methods for details). The observed average pairwise
diversity ( ) values for primigravidae (0.0582) and multigravidae
(0.0507) are similar (Table 3) suggesting that there is no influence
of gravidity or, by extension, host immunity on the overall
diversity of var2csa in placental infections. Still, this observed
pairwise diversity is considerably higher than observed for other
malarial antigens such as eba-175 (p=0.00366), ebl-1
(p=0.00321), and eba-140 (p=0.001) [39,40]. This highlights
that while var2csa is a conserved member of the var gene family, it is
highly polymorphic when compared to other malarial antigens
considered to be viable vaccine candidate antigens. When p is
calculated for each position in an alignment of DBL3X sequences
it is clear that the diversity in this domain is primarily found in the
first and second variable regions (V1 and V2), and to a lesser
degree the third variable region (V3) (Figure 3). While Tajima’s
D is not .1 when calculated over the entire DBL3X domain
(Table 3), certain regions of this domain do show evidence of
positive selection; that is, Tajima’s D (departure from neutrality) is
.1 for those regions exhibiting the highest degree of pairwise
diversity (Figure 2). This is not surprising as positive selection will
favor escape mutations. These results are in agreement with other
studies that have examined diversity in DBL3X [33,37], and
provide good evidence that this domain is a target of immune
selection.
Novel motifs identified in Kenyan samples
Amino acid sequence alignments are frequently used in the
analysis of protein structure, function and evolutionary relation-
ships. Analysis of positional amino acid conservation of sequences
can aid in identifying critical motifs and structurally important
residues. Dahlback et al [33] reported that the sequence motif
EIEKD at amino acid positions 1423–1427 in V2 was
overrepresented in primigravidae, while EIERE/EIEGE/GIERE
and GIEGE were predominantly found in multigravid women.
Four of these motifs, GIERE, EIEKD, EIERE, and GIEGE,
were present in the Kenyan DBL3X sequences, but the motif
EIEGE was not observed. GIEGE was somewhat overrepresent-
ed in multigravidae, with 69% versus 31% in primigravidae. The
motif EIEKD and EIERE/GIERE were not conclusively
gravidity-associated in these samples. Finally, unique to the
Kenyan samples, the motif TKQN at amino acid positions 1401–
1404 in V2 was mainly found in primigravidae and TKTK/
PQQK in multigravidae (Table 4). These motifs, therefore, show
Figure 1. VAR2CSA in placental parasites shows unprecendented diversity with no interindividual clustering. Maxiumum Liklihood
Tree of 79 Unique DBL3X Sequences. Sequences were aligned by translation. Consensus tree shown, with 50% cutoff. Taxa colored by placental
sample. Sequences from the same patient sample tend to group together in one to three clades with the exception of 0786-A09, denoted by an
asterisk.
doi:10.1371/journal.pone.0031565.g001
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the Fisher’s exact test to compare the novel motifs in
multigravidae and primigravidae. Overall, these results suggest
that the Senegalese and Kenyan parasite populations are
separated enough geographically to have developed distinct
motifs that may provide a biological advantage based upon
gravidity. It is also possible that host genotypic differences in
immune-relevant function have provided unique selective pres-
sures on local parasites, thus reflecting geographically unique
host/parasite co-evolution.
Figure 2. Identification of recombination events in a single patient and general protocol used for identifying recombination in all
patient samples using RDP4. (A) RDP4 generated recombination schematic indicating evidence of intra-segmental recombination. Regions of
recombination events, and corresponding insertions from donor sequences are depicted. Significant sites including nucleotide position(s) involved in
recombination are shown for the last recombinant (M_0608_H07). Significant nucleotide positions involved in recombination were checked in a
similar fashion for all other recombinants. Recombination events were only considered if at least three recombination analysis methods were in
agreement with the obtained results, a p-value of 0.05 or better was obtained, and the consensus recombination score was above the recommended
0.60 value. An example for recombinant M_0608_HO7 showing recombination signals identified by the (B) BOOTSCAN method, (C) RDP method, and
(D) GENECONV method are shown. Lastly, the MAXCHI matrices tool when necessary was used to determine the optimal locations of breakpoint
pairs, shown in (E). These graphically represent the probabilities of all potential breakpoint pairs that have the best associated p-values displayed by
the color key beside the matrix. Dark red peaks indicate the most probable positions of breakpoint pairs, for recombinant M_0608_HO7 these were at
nucleotide positions 438 and 733.
doi:10.1371/journal.pone.0031565.g002
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observed near the predicted binding pocket of CSA and
the critical amino acid residue arginine implicated in
binding to placental CSA is not absolutely conserved
Conservation analysis has proven to be a powerful indicator of
functional importance and has been used to determine residues
implicated in ligand binding [41,42], protein-protein interactions
[43,44], and functional specificity [44,45]. Although many
computation methods are available for determining the functional
importance of residues, it has been found that conservation is one
of the most powerful attributes in these applications [46]. Mapping
this information on a 3D structure can help visualize potential
functional surfaces (e.g. such as those exposed to host humoral
immunity). Toward this end, the protein structure of DBL3X
(Protein Data Bank: 3CPZ, [47]) was used as a template for
structural modeling of the 79 unique DBL3X sequences and
analysis of sequence conservation performed using the UCSF
Chimera molecular analysis program [48] (see Materials and
Methods for details). The structure of the DBL3X domain is made
up of three subdomains [47,49]. Subdomain I (S1) (Figure 4A,
green), primarily forms a large loop with little secondary
structure. Subdomain II (S2) (Figure 4A, dodger blue),
comprises four helices connected by loops. Subdomain III (S3)
(Figure 4A, magenta), is comprised of two anti-parallel helices.
Conservation analysis of DBL3X reveals that lowest sequence
conservation is focused around the predicted binding pocket,
suggesting this region may be under immune pressure (Figure 4B).
S3 has recently been identified as a minimal CSA binding region
and mutations of residues within this subdomain result in
substantial reduction of binding to placental CSA [50]. Of note,
Figure 3. Evidence for selective pressure in regions of the DBL3X domain showing the highest sequence diversity. Overview of
sequence diversity among DBL3X of Primigravidae and Multigravidae. The average pairwise similarity (p) and Tajima’s D for the aligned sequences,
over an 870 nucleotide window including Conserved (C1–4) and variable (V1–3) regions are shown.
doi:10.1371/journal.pone.0031565.g003
Table 3. Results from Tajima’s Neutrality Test.
mS p s Hp D
Primigravid35 172 0.195011 0.047353 0.058227 0.866659
Multigravid30 178 0.201130 0.050769 0.059910 0.695683
The Tajima test statistic [1] was estimated using MEGA4 [2]. All positions
containing gaps and missing data were eliminated from the dataset (Complete
deletion option). The abbreviations used are as follows: m=number of sites,
S=Number of segregating sites, ps=S/m, H=p s/a1,a n dp=nucleotide
diversity. D is the Tajima test statistic.
doi:10.1371/journal.pone.0031565.t003
Table 4. Novel motifs identified in Kenyan samples are
associated with host immune status (gravidity).
Sequence Motif Primigravid Multigravid
EIKD 59% 41%
EIERE/GIERE 41% 59%
GIEGE 31% 69%
TKQN* 28% 72%
TKTK* 80% 20%
PQQK* 75% 25%
Motifs TKTK/PQQK are predominately found in primigravidae and TKQN in
multigravidae. Sequence motifs (highlighted in grey) identified in Dahlback et
al. [33] show no strong parity association in Kenyan samples. * P,0.001, by c
2
test.
doi:10.1371/journal.pone.0031565.t004
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the N-terminal domains [18], including the DBL3X domain [20],
provide high specificity binding comparable to full-length
VAR2CSA. Furthermore, as suggested by Bigley et al., only
sequences between the NTS and the DBL3X appear to induce
inhibitory antibodies [51]. This would suggest that DBL3X in the
presence of other N-terminal domains plays a critical role in the
native protein structure.
Epitopes exposed on the surface of native VAR2CSA may
therefore be accessible to immunoglobulins and, as a result, be
under strong selective pressure for escape mutations. While host
immune responses exert strong selective pressures resulting in
amino acid positions that exhibit a pattern of escape mutations,
there can be functional consequences to these changes which drive
select for reversion mutations in a naı ¨ve host. Such mutations
within or flanking functionally important epitopes can have two
effects: (1) immune evasion through mutation from a wild type
sequence driven by selective pressure and (2) changing ligand
binding for potentially improved or reduced affinity. This process
of mutation and reversion has been termed ‘‘toggling’’ in a recent
study by Delport et al. [52] who used a probabilistic model of
protein sequences in HIV-1 to demonstrate that there is a large
number of sites evolving under selective pressure, but which also
exhibit low sequence diversity. These toggling sites, typically, were
found to switch between just 2 or 3 amino acids when comparing
different viral isolates. That observation prompted an evaluation of
Figure 4. Toggling Amino Acid Regions and Amino Acid Conservation of VAR2CSA DBL3X Domain. (A) DBL3X surface and ribbon
representation of subdomain I (green), subdomain II (dodger blue), subdomain III (magenta) and toggling regions (red). CSA sulfate ion is shown in
the proposed binding pocket. A proposed binding residue of CSA, arginine1467 was identified as a toggling residue (shown by blown up image). (B)
Analysis of Amino Acid Conservation of VAR2CSA DBL3X domain. Percent sequence conservation from highest 100% (red) to lowest 40% (yellow)
based on an alignment of 79 DBL3X sequences isolated from twelve Kenyan placental blood samples is shown on a DBL3X surface based model.
Dotted circles indicate the predicted binding pocket region for CSA, shown with an SO4 molecule. Insufficient sequence data for analysis is depicted
in grey.
doi:10.1371/journal.pone.0031565.g004
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between wild type and escape amino acids is evident and whether
or not such toggling sites can be used to identify specific regions of
DBL3X that are subject to immune pressure and, therefore, likely
to encode functionally important amino acids. Toward this end,
the 79 unique DBL3x sequences were submitted for toggling
analysis to the Datamonkey server (see Materials and Methods for
details) and the results mapped to the protein structure of DBL3X
as above. This analysis yielded a total of 27 toggling amino acids,
primarily found on domains S1 and S2 (Figure 3). It is interesting
to note that an arginine residue (Arg
1467) on S3, previously
implicated in binding to the placental receptor CSA [15,47,50],
toggles between arginine (R), glutamine (Q), and glutamic acid (E).
A recent study by Khunrae et al. [15] suggests that CSA binding is
mediated by the positively charged patch in the binding pocket.
This would imply that the toggling between a positive (R) –
negative (Q) – positive (E) charge may modulate the binding
specificity of the N-terminal domains to placental CSA and reflects
the pressure on the parasite to forego efficient binding in the face
of acquired immune clearance mechanisms. Of note, a single
amino acid substitution in P. vivax Duffy-binding protein (PvDBP)
was found to dramatically alter both its binding affinity and
antigenic character [53]. To characterize the individual sites
relative to immune status, relative proportions of toggling amino
acids at each site in primigravidae and multigravidae were
compared (Table S1). As shown in Figure 5, nine of the 27
toggling sites were found to toggle differentially as a function of
gravidity. Since host immune responses exert strong selective
pressures favoring mutations that prevent immune recognition,
these toggling sites (especially Arginine
1467 on S3) may represent
important epitopes that, when targeted by host antibody
responses, force the parasite to choose between efficient binding
to CSA and mutation to facilitate immune evasion. A consequence
of such mutations may be decreased specificity for binding of
infected erythrocytes to placental CSA. This hypothesis would be
intriguing to test in future studies and extend the toggling analysis
to the NTS-DBL2X domain region.
Concluding Remarks
Numerous studies have addressed sequence polymorphism in
var2csa. After performing similar alignment, tree and structural
analyses as previous studies, the present results reveal agreements
and discrepancies with the available published data. Notably, the
present analysis revealed a high level of parasite genetic
complexity within individual patient samples at the var2csa locus.
Given that an average of nine clones per sample were examined,
the true genetic complexity in each sample is likely to be
considerably higher and will require additional investigation.
While it is possible that the multicopy nature of the var2csa gene
in some isolates may account for some of the observed complexity,
we provide evidence that intra-segmental recombination and
amino acid mutations driven by immune pressure appear to play a
critical role in generating the observed diversity. While we
examined a limited set of samples, our results reveal several
statistically significant gravidity-associated motifs; intriguingly, the
patterns and identity of the motifs differ from those previously
reported in Senegalese samples [33]. This discrepancy may reflect
geographically unique host/parasite co-evolution, but will require
analysis of additional samples from distinct greographic regions to
confirm this hypothesis. An important advance in this study was
the application of in silico methods to identify recombination events
and functionally important positions that toggle between a limited
set of amino acids and may impact binding to placental CSA.
Overall, the nine toggling positions that vary significantly between
primigravidae and multigravidae in terms of which amino acid is
preferred provide indirect evidence that acquired immunity to
CSA-binding parasites that is elicited by repeated exposure to PM
selects for parasites with different sequences than those used by
parasites occupying an immunologically naı ¨ve environment. It is of
particular interest that most of these cases reveal a tendency
toward homogeneity in multigravidae. Further study will be
required to evaluate the extent to which the toggling in the full
NTS-DBL3X region is influenced by immune responses and
affects efficiency of binding to CSA.
As previously observed, detailed sequence analysis coupled with
3D modeling of DBL3X reveals that this domain is very complex.
However, the genetic complexity and multiplicity of infection
identified in this study is likely to have underestimated the true
diversity of infection in pregnant women. The toggling amino acid
sites identified in this study were limited to the DBL3X domain; it
would be interesting to test the hypothesis that successful parasites
have limited choices for some residues within VAR2CSA,
especially the N-terminal region. Our data are theoretically
consistent with a dynamic host/parasite relationship in which
immune pressure in a multigravid host selects for escape mutations
that later revert back under selection for binding function in a
naı ¨ve, primigravid host. Should these sites be confirmed as targets
for protective antibodies, then such information could be used in
the design of a VAR2CSA vaccine construct that targets different
serological variants of these regions.
Materials and Methods
Sample Collection
The samples used in this study were derived from a project
designed to assess gravidity-dependent acquisition of cell-mediated
immunity to PM as previously described [54]. In brief, samples
were collected from women delivering at Siaya District Hospital in
western Kenya. This is an area with stable malaria transmission all
year round with reported entomological inoculation rates (EIR)
estimated as high as 31 infective bites/person/year [55]. Informed
consent was obtained from potential clients in agreement with
Kenya Medical Research Institute Ethical Review Committee, the
Institutional Review Boards of the University of Georgia, the
Centers for Disease Control and Prevention, and the National
Institutes of Health. All participants provided informed, written
consent under the auspices of these approved protocols. Imme-
diately post-delivery, placentas were collected and maternal
placental blood obtained either by the prick method [56] or
perfusion [57] under aseptic conditions. Placental parasitemia was
Figure 5. Toggling amino acids with gravidity-associated
preferences. A total of nine sites were identified as varying significant
between primigravidae (P) and multigravidae (M), shown here in
relative proportion of toggling amino acids at each site (see Table S1 for
details and other toggling sites). The chi-square test (or Fisher’s exact
test when appropriate) was used; all sites, P,0.05.
doi:10.1371/journal.pone.0031565.g005
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stained thick smear of maternal placental prick blood and is
reported as parasitemia per 300 white blood cells. Each of the
collected samples is well defined by clinical data (age, gravidity,
birth weight). Samples for this study were collected over a time
span of 1.5 years.
Amplification and Sequencing
DNA was extracted from placental blood samples using the
illustra
TM blood genomicPrep
TM Mini Spin Kit (GE Healthcare,
Little Chalfont, Buckinghamshire, UK) according to manufactur-
er’s instructions. Primers to conserved regions of the 59
(BacdiDBL3F - CACCATGAATTATATTCGTGGGTGTCAA)
and 39 (BacdiDBL3R – ATTTGCTGATATACATTCAGG)
boundaries of the var2csa DBL3X domain were designed from
an alignment of 5 var2csa sequences. For each sample, the
DBL3Xdomain was amplified using the proof reading ExTaq
(Takara Bio Inc.) and cloned via the TOPO reaction into the
pENTR/D-TOPO vector (Invitrogen, Carlsbad, CA). For each
sample a minimum of three independent amplification and TOPO
reactions were performed. The samples were chosen to include a
range of gravidities with 5 primigravid, 2 secundigravid and 5
multigravid women. The TOPO reactions were transformed into
competent E. coli and plated to obtain cloned plasmids. Colonies
containing plasmids with a DBL3X insert were identified via
colony PCR. Multiple clones were obtained for each sample and
submitted for sequencing. A total of 6 overlapping reads were
obtained for each sequence using vector primers and four
sequence specific primers (DBL3F.2 TGATTATAAGAATAT-
GATTTTGGGTAC, DBL3R.2 TTTATATCTTCTTGTAAT-
TTTCCAATG, DBL3F.3 GAATACCACGATAAAGGTACA-
GC, DBL3R.3 CCACGAAACGAACTGATCCTC).
Following sequencing, all chromatograms were checked for
accuracy and quality, and reads in both directions were assembled
into full length contigs for each clone using the Geneious software
package (Biomatters Ltd, Auckland NZ). We obtained between 7
and 13 complete DBL3X sequences per sample, with the
exception of one sample for which a single sequence was obtained.
As a control, the amplification of DBL3Xregion from the var2csa of
isolate FCR3/IT4 was used. All three independent FCR3
sequences that were obtained perfectly matched the reported
sequence (GenBank accession number AY372123), suggesting a
very low error rate. From the 10 placental blood samples a total of
108 sequences were obtained. Taking a conservative approach,
sequences were only considered unique if they differed by more
than 2 base pairs. All unique sequences, 79 in all, were submitted
to Genbank under accession numbers JN615483–JN615561.
Phylogenetic Analysis and Neutrality Test
To characterize the 79 unique DBL3X sequences, along with
the FCR3/IT4 sequence, alignments were done in Geneious Pro
using the ClustalW algorithm and phylogenetic analysis was
performed in MEGA [58]. Tajima’s D test as implemented in both
MEGA and DnaSP [59] was used to test 35 multigravidae and 30
primigravidae DBL3X sequences for departure from neutrality in
the nucleotide frequency distributions (secundigravidae were
excluded from analysis since only 15 sequences from 2 individuals
were available). This is determined by divergence in the values of p
(observed average pairwise nucleotide diversity) and h (expected
nucleotide diversity under neutrality derived from the number of
segregating sites, S). Elevated p and positive values to D would
confer a balancing selection of nucleotide sites that would be
maintained at intermediate frequencies.
Multilocus Genotyping
Twelve DNA samples were assayed for seven putatively neutral
microsatellites as described previously [60]. The neutral markers
used were TA1 found on chromosome 6; poly a, chromosome 4;
PfPK2, chromosome 12; TA109, chromosome 6 and 2490,
chromosome 10; these neutral markers were previously described
and used in various studies in South America [51,61,62,63]. The
final two neutral microsatellite markers used were C2M34,
chromosome 2 and C3M69, chromosome 3 [64]. Briefly, the
amplification products were labeled with fluorescent dyes (HEX or
FAM) and assayed for size on an Applied Biosystems 3130xl
sequencer (Applied Biosystems, Foster City, CA). The fragments
were then scored with GeneMapper software v.3.7 (Applied
Biosystems, Foster City, CA) using default microsatellite settings,
whereby bands smaller than 1000 relative fluorescence units (rfu)
were defined as background. Samples for which we obtained no
amplification in some loci or for which we obtained multiple alleles
at certain loci were re-analyzed to complete the analysis.
3D Structure Modeling, Percent Sequence Conservation
The protein structure of DBL3X (Protein Data Bank: 3CPZ,
[47]) was used as a template for structure modeling. Structural
visualizations and labeling was done using the UCSF Chimera
molecular analysis program [48]. Briefly, the 79 unique DBL3x
sequences including the FCR3/IT4 sequence was aligned using
Chimera’s Multialign View feature and sequence conservation was
calculated using the mavPercentConservation method. The
mavPercentConservation method is based on the AL2CO
algorithm. The algorithm of AL2CO program performs calcula-
tions in two steps. First, amino acid frequencies at each position
are estimated and then the conservation index is calculated from
these frequencies. The results were then mapped to the protein
structure of DBL3x (Protein Data Bank: 3CPZ, [47]) using the
following color parameters: lowest (40%) and highest (100%)
sequence conservation are represented in yellow and red,
respectively. Insufficient data (shown in grey) indicates amino
acid locations that were missing from our sequences.
Toggling Amino Acid Analysis and 3D Structure Mapping
Toggling amino acid analysis was performed on 79 sequences
obtained from 12 placental blood samples using Datamonkey: a
suite of phylogenetic analysis tools for evolutionary biology [65].
Briefly, the sequences were uploaded on the Datamonkey server
and analysis was performed using the following four steps: First, a
nucleotide model was fitted to the DBL3X sequences using
maximum likelihood to obtain branch lengths and substitution
rates. Second, the data were fitted to obtain a global v=dN/dS
ratio. Next, codon ancestral sequences were constructed site by site
using maximum likelihood. Lastly, a test of escape and reversion
from/to the wild type was conducted and results reported with the
following summary statistics: the likelihood ratio test statistic, P-
value, toggling rate and the proportion of time each site ‘‘spends’’
in the wild-type, single-step and multiple-step escape amino acid
states. Each of the toggling amino acids was then mapped to the
template sequence of the protein structure of DBL3X (Protein
Data Bank: 3CPZ, [47]) and analyzed using the UCSF Chimera
molecular analysis program.
Statistical Analysis
The chi-square test (or Fisher’s exact test when appropriate) was
used to compare novel motifs and toggling amino acid proportions
between multigravidae and primigravidae. Statistically significant
(P,0.05) sites were mapped using WebLogo [66].
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Figure S1 Amino acid alignment of 79 var2csa DBL3x
domains. Individual subdomains are denoted by arrows above
alignment. Toggling sites are marked by a ‘‘T’’ above the relevant
amino acid site. Motifs identified in this study and in Dahlback at
al. [33] are denoted by black boxes. Amino acid residues are
colored according to conservation.
(PDF)
Table S1 Relative proportions of toggling amino acids
at each amino acid position. Amino acids found to toggle
were stratified by gravidity. Relative proportions of occupying
amino acids at each respective site within each group are
represented as a percentage. Nine sites (shown in grey and
denoted by a asterisk) were found to differ statistically significantly
(c2, P,0.05) between the gravidity groups.
(PDF)
Table S2 Summary table of recombination analysis via
RDP4 [38] at a global level (all sequences) and individual
samples (same patient clusters). Data shows recombination
breakpoints related to the sequence of the transferred fragment
(major parent) and sequence closely related to transferred
fragment (minor parent) including resulting recombinant. For
statistical analysis the Chi-square statistical test in RDP4 was used.
(PDF)
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